Tadalafil
Product Images NDC 76519-1225

This is a warning for a drug called Tadalafil, which should not be taken by anyone other than the person to whom it was prescribed, and its dispensing without a prescription is illegal. The drug should be stored away from children and kept at a temperature between 66-77°F. There are different batches of Tadalafil 20mg tabs with various lot numbers and expiry dates manufactured by different companies. The drug is supposed to be taken as directed by a physician. The label has the NDC (National Drug Code) of the drug and its manufacturer. The document is not available in its entirety, so there might be more information about the drug that is missing.*

This appears to be a label for Tadalafil 5mg tablets with various identifying numbers and manufacturer information. The label cautions to use as directed by a physician and states that it should only be given to the person for whom it was prescribed. It also warns against dispensing without a prescription and to keep the medication out of reach of children. The manufacturer information is listed several times and there are different lot numbers associated with the medication.*

This is the packaging for Tadalafil 10mg tablet, a medication used as directed by a physician. The medication is similar to Cialis (Gialis) and the lot number is ABOOCD with an expiration date of 00100. The manufacturer is Teva and the product is not available over the counter. The packaging includes cautionary statements about keeping it out of reach of children and only using as directed by the physician. The packaging provides necessary information such as the National Drug Code (NDC), which is 76518-1227-XX, the manufacturer, MFG NDC 00033-3013-56, and the distributor, H.J Harkins Co., Inc. It is recommended to store the medication in dry places with temperatures ranging from 66-77 F (18-25°C).*

The text describes a chart or graph showing the standing and supine systolic blood pressure readings in mmHg. It also mentions the medications taken for the experiment, including tacalafi 20 mg and doxazosin 8 mg, as well as a placebo and doxazosin 8 mg. The x-axis of the chart is labeled as "time post-dose (h)".*

Systolic BP (mmHg) readings were recorded for different doses and timings of tadalafil and doxazosin. The time after administration is also mentioned. Likely a pharmacological study.*

The text describes a graph of plasma Tadalafil concentration (in mcg/L) over time (in hours) following different doses of Tadalafil medication. The graph indicates the concentration levels after a single 20mg dose, a single 5mg dose, and a daily 5mg dose for 5 consecutive days.*

This appears to be the result of a medical test or study involving Tadalafil 5mg and a placebo. The table shows the results in terms of the "IPSS Total Score" over a duration of 8 and 12 weeks. However, without additional information or context, it is difficult to determine the purpose or significance of these findings.*

This text seems to be a graph or table that shows the change in IPSS total score with two different treatments, Tadalafil (5mg) and Placebo. The asterisk (*) indicates that the difference between the two groups is statistically significant at a level of p<0.01. It also includes a time axis ranging from 2 to 4 weeks of treatment.*